SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Celgene International Sárl Release: Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of ACR20 in the First Phase 3 Study (Palace-1) in Patients With Psoriatic Arthritis